Inside Precision Medicine Marketplace Healthcare Informatics Decision Support

Genomoncology
Decision Support

GenomOncology’s precision oncology solutions enhance decision support by combining proprietary technologies, curation processes, data-delivery systems, and public and licensed annotation sets, with internal clinical data. This outputs actionable oncology treatment options and insights to improve overall patient care.




Genomoncology

1138 West 9th St Suite 400
Cleveland, OH 44113, USA
440.617.6087
https://www.genomoncology.com





Features & Specs

  • Precision Oncology API Suite
    • Curated Content – Access all biomarker-based clinical trials and therapies curated through our in-house curation team and partnerships with leading content institutions.
    • Accurate & Up-to-Date Variant Data – Review an extensive annotation data set that includes the latest variant information, which is updated quarterly with new and relevant information.
    • Genomic Model – Parse complex mutations, including protein expressions, chromosomal markers, and markers of genomic instability for comprehensive matching.
    • Disease Ontology – Obtain an up-to-date, expandable disease hierarchy, disease codes, and institutional codes to enable enhanced treatment matching for patients.
    • Clinical Data – Track a patient’s medical history for patient treatment matching or for large scale analysis, with both institution-specific and public clinical data.
    • Decision Support – Match patients to appropriate clinical trials, therapies, and prognoses based on their biomarkers, disease, and prior therapies.
  • Precision Decision
    • Match Results – Access all biomarker-based clinical trials and biomarker-driven therapies curated through our in-house curation team and partnerships with leading content institutions.
    • Cohort Identification – Apply various filtering criteria to patients in your database to identify cohorts of patients potentially eligible for clinical trials.
  • Molecular Tumor Board
    • Match Results – Access all biomarker-based clinical trials and biomarker-driven therapies curated through our in-house curation team and partnerships with leading content institutions.
    • Final Recommendations – Create case summaries, meeting summaries, and Molecular Tumor Board presentations using the solution’s flexible reporting tools.
  • Pathology Workbench
    • Variant Analysis – Make informed variant interpretation and treatment recommendations with a highly automated, flexible review workflow.
    • Output Report – Create fully customized reports, with the ability to change layout, formatting, and content, based on the overall needs of the lab.

Features & Specs

  • Precision Oncology API Suite
    • Curated Content – Access all biomarker-based clinical trials and therapies curated through our in-house curation team and partnerships with leading content institutions.
    • Accurate & Up-to-Date Variant Data – Review an extensive annotation data set that includes the latest variant information, which is updated quarterly with new and relevant information.
    • Genomic Model – Parse complex mutations, including protein expressions, chromosomal markers, and markers of genomic instability for comprehensive matching.
    • Disease Ontology – Obtain an up-to-date, expandable disease hierarchy, disease codes, and institutional codes to enable enhanced treatment matching for patients.
    • Clinical Data – Track a patient’s medical history for patient treatment matching or for large scale analysis, with both institution-specific and public clinical data.
    • Decision Support – Match patients to appropriate clinical trials, therapies, and prognoses based on their biomarkers, disease, and prior therapies.
  • Precision Decision
    • Match Results – Access all biomarker-based clinical trials and biomarker-driven therapies curated through our in-house curation team and partnerships with leading content institutions.
    • Cohort Identification – Apply various filtering criteria to patients in your database to identify cohorts of patients potentially eligible for clinical trials.
  • Molecular Tumor Board
    • Match Results – Access all biomarker-based clinical trials and biomarker-driven therapies curated through our in-house curation team and partnerships with leading content institutions.
    • Final Recommendations – Create case summaries, meeting summaries, and Molecular Tumor Board presentations using the solution’s flexible reporting tools.
  • Pathology Workbench
    • Variant Analysis – Make informed variant interpretation and treatment recommendations with a highly automated, flexible review workflow.
    • Output Report – Create fully customized reports, with the ability to change layout, formatting, and content, based on the overall needs of the lab.